Jaw and long bone marrow derived osteoclasts differ in shape and their response to bone and dentin

Biochemical and Biophysical Research Communications

Volumn 409, Issue 2, 2011, Pages 205-210

  Azari, Azin ^a   Schoenmaker, Ton ^a,b   de Souza Faloni, Ana Paula ^c   Everts, Vincent ^b   De Vries, Teun J ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bone marrow; Jaw; Long bone; Mineralized tissues; Osteoclast diversity

Indexed keywords

ACTIN; COLONY STIMULATING FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW; BONE MARROW CELL; CONTROLLED STUDY; DENTIN; JAW; LONG BONE; MACROPHAGE; MALE; MANDIBLE; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; BONE AND BONES; BONE MARROW CELLS; CELL CYCLE; CELL DIFFERENTIATION; CELL SHAPE; DENTIN; MACROPHAGE COLONY-STIMULATING FACTOR; MALE; MANDIBLE; MICE; MICE, INBRED C57BL; NF-KAPPA B; OSTEOCLASTS; RANK LIGAND;

EID: 79957919737     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.04.120     Document Type: Article

References (21)

1. Everts V., de Vries T.J., Helfrich M.H. Osteoclast heterogeneity: lessons from osteopetrosis and inflammatory conditions. Biochim. Biophys. Acta 2009, 1792:757-765.
2. Helfrich M.H. Osteoclast diseases and dental abnormalities. Arch. Oral Biol. 2005, 50:115-122.
3. Everts V., Korper W., Jansen D.C., Steinfort J., Lammerse I., Heera S., Docherty A.J.P., Beertsen W. Functional heterogeneity of osteoclasts: matrix metalloproteinases participate in osteoclastic resorption of calvarial bone but not in resorption of long bone. FASEB J. 1999, 13:1219-1230.
4. Everts V., Korper W., Hoeben K.A., Jansen I.D., Bromme D., Cleutjens K.B., Heeneman S., Peters C., Reinheckel T., Saftig P., Beertsen W. Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: differences between calvaria and long bone. J. Bone Miner. Res. 2006, 21:1399-1408.
5. Shorey S., Heersche J.N., Manolson M.F. The relative contribution of cysteine proteinases and matrix metalloproteinases to the resorption process in osteoclasts derived from long bone and scapula. Bone 2004, 35:909-917.
6. Perez-Amodio S., Beertsen W., Everts V. (Pre-)osteoclasts induce retraction of osteoblasts prior to their fusion to osteoclasts. J. Bone Miner. Res. 2004, 19:1722-1731.
7. Zenger S., Ek-Rylander B., Andersson G. Long bone osteoclasts display an augmented osteoclast phenotype compared to calvarial osteoclasts. Biochem. Biophys. Res. Commun. 2010, 394:743-749.
8. Jansen I.D., Mardones P., Lecanda F., de Vries T.J., Recalde S., Hoeben K.A., Schoenmaker T., Ravesloot J.H., van Borren M.M., van Eijden T.M., Bronckers A.L., Kellokumpu S., Medina J.F., Everts V., Oude Elferink R.P. Ae2a,b-deficient mice exhibit osteopetrosis of long bones but not of calvaria. FASEB J. 2009, 23:3470-3481.
9. de Vries T.J., Schoenmaker T., Hooibrink B., Leenen P.J., Everts V. Myeloid blasts are the mouse bone marrow cells prone to differentiate into osteoclasts. J. Leukoc. Biol. 2009, 85:919-927.
10. Jacquin C., Gran D.E., Lee S.K., Lorenzo J.A., Aguila H.L. Identification of multiple osteoclast precursor populations in murine bone marrow. J. Bone Miner. Res. 2006, 21:67-77.
11. de Souza Faloni A.P., Schoenmaker T., Azari A., Katchburian E., Cerri P.S., de Vries T.J., Everts V. Jaw and long bone marrows have a different osteoclastogenic potential. Calcif. Tissue Int. 2011, 88:63-74.
12. Yao Z., Xing L., Qin C., Schwarz E.M., Boyce B.F. Osteoclast precursor interaction with bone matrix induces osteoclast formation directly by an interleukin-1-mediated autocrine mechanism. J. Biol. Chem. 2008, 283:9917-9924.
13. Gramoun A., Azizi N., Sodek J., Heersche J.N., Nakchbandi I., Manolson M.F. Fibronectin inhibits osteoclastogenesis while enhancing osteoclast activity via nitric oxide and interleukin-1beta-mediated signaling pathways. J. Cell Biochem. 2010, 111:1020-1034.
14. Fuller K., Lean J.M., Bayley K.E., Wani M.R., Chambers T.J. A role for TGFbeta(1) in osteoclast differentiation and survival. J. Cell Sci. 2000, 113(Pt 13):2445-2453.
15. van den Bos T., Speijer D., Bank R.A., Bromme D., Everts V. Differences in matrix composition between calvaria and long bone in mice suggest differences in biomechanical properties and resorption: special emphasis on collagen. Bone 2008, 43:459-468.
16. de Vries T.J., Mullender M.G., van Duin M.A., Semeins C.M., James N., Green T.P., Everts V., Klein-Nulend J. The Src inhibitor AZD0530 reversibly inhibits the formation and activity of human osteoclasts. Mol. Cancer Res. 2009, 7:476-488.
17. de Vries T.J., Schoenmaker T., Beertsen W., van der Neut R., Everts V. Effect of CD44 deficiency on in vitro and in vivo osteoclast formation. J. Cell. Biochem. 2005, 94:954-966.
18. Vesely P., Boyde A., Jones S.J. Behaviour of osteoclasts in vitro: contact behaviour of osteoclasts with osteoblast-like cells and networking of osteoclasts for 3D orientation. J. Anat. 1992, 181:277-291.
19. Jones S.J., Boyde A. Some morphological observations on osteoclasts. Cell Tissue Res. 1977, 185:387-397.
20. Sloofman L.G., Verdelis K., Spevak L., Zayzafoon M., Yamauchi M., Opdenaker L.M., Farach-Carson M.C., Boskey A.L., Kirn-Safran C.B. Effect of HIP/ribosomal protein L29 deficiency on mineral properties of murine bones and teeth. Bone 2010, 47:93-101.
21. Geblinger D., Addadi L., Geiger B. Nano-topography sensing by osteoclasts. J. Cell Sci. 2010, 123:1503-1510.